US Patent 10946078 Treatment of canine atopic dermatitis
Patent 10946078 was granted and assigned to Benchmark Animal Health on March, 2021 by the United States Patent and Trademark Office.
All edits
Edits on 12 Dec, 2023
Golden AI
Edits made to:
Article (+454 characters)
Article
Patent abstract
The present invention relates to compositions, immunogenic or vaccine compositions and pharmaceutical compositions for the prevention or treatment of canine atopic dermatitis (CAD). Furthermore, the invention provides methods for preventing or treating CAD. The compositions of the invention induce efficient immune responses, in particular antibody responses, in dogs and are, therefore, useful for the treatment and/or prevention of CAD.
Edits on 9 Oct, 2023
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Inventor Names
Kaspars Tars0
Edits on 18 May, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 28 Sep, 2022
Golden AI
Infobox
Patent Citations
Edits on 23 Sep, 2022
Golden AI
Infobox
Is a
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
109460780
Date of Patent
March 16, 2021
0Patent Application Number
160971560
Date Filed
April 26, 2017
0Official Website
Patent Citations
Patent Primary Examiner
Edits on 18 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 10 Feb, 2022
Golden AI
Edits made to:
Infobox (+10 properties)
US Patent 10946078 Treatment of canine atopic dermatitis
Infobox
Is a
Patent applicant
Current assignee
Patent jurisdiction
Patent number
10946078
Date of patent
March 16, 2021
Patent application number
16097156
Date Filed
April 26, 2017
Patent citations
Patent primary examiner
Find more entities like US Patent 10946078 Treatment of canine atopic dermatitis
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
